The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
Sports reporter Nick Walters sits down with Zach Whitecloud to hear how he has felt embraced by the Vegas community and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback